Afoxolaner is an isoxazoline compound characterized by a good safety profile and extended effectiveness against fleas and ticks on dogs following a single oral dose administration. It acts by inducing hyperexcitation in the nervous system of susceptible insects. Afoxolaner is selectively toxic to the insect and acarine nervous system.
Afoxolaner
Specifications
Veterinary
Oral
Commercial
FEATURED Products
Related Media
New Product Development
Where our FDA approved laboratory begins developing products, formulating and validating methods to ensure quality.
Compliance Audits
Where we audit and champion our partner factories to exceed cGMP standards set by authorities.
Regulatory Services
Where all submissions are filed with the knowledge and experience of our 550+ worldwide approvals on record.